Treatment and management of FXTAS

Elizabeth Berry-Kravis, Deborah A. Hall, Maureen A. Leehey, Randi J Hagerman

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Citations (Scopus)

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) affects older adult carriers of the FMR1 premutation and can be associated with a broad array of clinical symptoms and presentations including tremor, ataxia, parkinsonism, executive function disturbance and dementia, psychiatric symptoms of anxiety, depression and disinhibition, peripheral neuropathy, autonomic dysfunction, hormonal dysfunction, and pain syndromes. Although controlled trials have not been carried out in individuals with FXTAS, there is information available regarding symptomatic treatments. Treatment is generally supportive, directed at component symptoms that are most problematic, and makes use of evidence regarding effectiveness of medications and other interventions for treatment of disorders that have phenotypic overlap with FXTAS. This chapter summarizes available treatments and supports that can be helpful for persons with FXTAS.

Original languageEnglish (US)
Title of host publicationThe Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)
PublisherSpringer New York
Pages137-154
Number of pages18
ISBN (Print)9781441958051, 9781441958044
DOIs
StatePublished - 2010

Fingerprint

Executive Function
Parkinsonian Disorders
Peripheral Nervous System Diseases
Tremor
Ataxia
Therapeutics
Psychiatry
Dementia
Anxiety
Depression
Pain
Fragile X Tremor Ataxia Syndrome

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Berry-Kravis, E., Hall, D. A., Leehey, M. A., & Hagerman, R. J. (2010). Treatment and management of FXTAS. In The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS) (pp. 137-154). Springer New York. https://doi.org/10.1007/978-1-4419-5805-1_9

Treatment and management of FXTAS. / Berry-Kravis, Elizabeth; Hall, Deborah A.; Leehey, Maureen A.; Hagerman, Randi J.

The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS). Springer New York, 2010. p. 137-154.

Research output: Chapter in Book/Report/Conference proceedingChapter

Berry-Kravis, E, Hall, DA, Leehey, MA & Hagerman, RJ 2010, Treatment and management of FXTAS. in The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS). Springer New York, pp. 137-154. https://doi.org/10.1007/978-1-4419-5805-1_9
Berry-Kravis E, Hall DA, Leehey MA, Hagerman RJ. Treatment and management of FXTAS. In The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS). Springer New York. 2010. p. 137-154 https://doi.org/10.1007/978-1-4419-5805-1_9
Berry-Kravis, Elizabeth ; Hall, Deborah A. ; Leehey, Maureen A. ; Hagerman, Randi J. / Treatment and management of FXTAS. The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS). Springer New York, 2010. pp. 137-154
@inbook{922e84b2e86b46b6aa77bc2cedfb9c6c,
title = "Treatment and management of FXTAS",
abstract = "Fragile X-associated tremor/ataxia syndrome (FXTAS) affects older adult carriers of the FMR1 premutation and can be associated with a broad array of clinical symptoms and presentations including tremor, ataxia, parkinsonism, executive function disturbance and dementia, psychiatric symptoms of anxiety, depression and disinhibition, peripheral neuropathy, autonomic dysfunction, hormonal dysfunction, and pain syndromes. Although controlled trials have not been carried out in individuals with FXTAS, there is information available regarding symptomatic treatments. Treatment is generally supportive, directed at component symptoms that are most problematic, and makes use of evidence regarding effectiveness of medications and other interventions for treatment of disorders that have phenotypic overlap with FXTAS. This chapter summarizes available treatments and supports that can be helpful for persons with FXTAS.",
author = "Elizabeth Berry-Kravis and Hall, {Deborah A.} and Leehey, {Maureen A.} and Hagerman, {Randi J}",
year = "2010",
doi = "10.1007/978-1-4419-5805-1_9",
language = "English (US)",
isbn = "9781441958051",
pages = "137--154",
booktitle = "The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)",
publisher = "Springer New York",

}

TY - CHAP

T1 - Treatment and management of FXTAS

AU - Berry-Kravis, Elizabeth

AU - Hall, Deborah A.

AU - Leehey, Maureen A.

AU - Hagerman, Randi J

PY - 2010

Y1 - 2010

N2 - Fragile X-associated tremor/ataxia syndrome (FXTAS) affects older adult carriers of the FMR1 premutation and can be associated with a broad array of clinical symptoms and presentations including tremor, ataxia, parkinsonism, executive function disturbance and dementia, psychiatric symptoms of anxiety, depression and disinhibition, peripheral neuropathy, autonomic dysfunction, hormonal dysfunction, and pain syndromes. Although controlled trials have not been carried out in individuals with FXTAS, there is information available regarding symptomatic treatments. Treatment is generally supportive, directed at component symptoms that are most problematic, and makes use of evidence regarding effectiveness of medications and other interventions for treatment of disorders that have phenotypic overlap with FXTAS. This chapter summarizes available treatments and supports that can be helpful for persons with FXTAS.

AB - Fragile X-associated tremor/ataxia syndrome (FXTAS) affects older adult carriers of the FMR1 premutation and can be associated with a broad array of clinical symptoms and presentations including tremor, ataxia, parkinsonism, executive function disturbance and dementia, psychiatric symptoms of anxiety, depression and disinhibition, peripheral neuropathy, autonomic dysfunction, hormonal dysfunction, and pain syndromes. Although controlled trials have not been carried out in individuals with FXTAS, there is information available regarding symptomatic treatments. Treatment is generally supportive, directed at component symptoms that are most problematic, and makes use of evidence regarding effectiveness of medications and other interventions for treatment of disorders that have phenotypic overlap with FXTAS. This chapter summarizes available treatments and supports that can be helpful for persons with FXTAS.

UR - http://www.scopus.com/inward/record.url?scp=84861221953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861221953&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-5805-1_9

DO - 10.1007/978-1-4419-5805-1_9

M3 - Chapter

SN - 9781441958051

SN - 9781441958044

SP - 137

EP - 154

BT - The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)

PB - Springer New York

ER -